Bonesupport Holding AB (STU:2B4) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2B4 Bonesupport Holding AB STU:2B4
75 GF Score
Price €18.64
GF Value €40.35
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bonesupport Holding AB Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bonesupport Holding AB  (STU:2B4) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bonesupport Holding AB Cyclically Adjusted PS Ratio Related Terms


Bonesupport Holding AB Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Bonesupport Holding AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonesupport Holding AB Cyclically Adjusted PS Ratio Chart

Bonesupport Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 46.77 73.59 28.45

Bonesupport Holding AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.30 55.05 28.27 27.47 27.50

STU:2B4 vs ISRG, BDX, RMD: Cyclically Adjusted PS Ratio Comparison

For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bonesupport Holding AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bonesupport Holding AB's Cyclically Adjusted PS Ratio falls into.


STU:2B4
75GF Score
Bonesupport Holding AB STU:2B4
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonesupport Holding AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bonesupport Holding AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Bonesupport Holding AB's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.489/134.6100*134.6100
=0.489

Current CPI (Jun. 2026) = 134.6100.

Bonesupport Holding AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.057 101.138 0.076
201612 0.062 102.022 0.082
201703 0.070 102.022 0.092
201706 0.127 102.752 0.166
201709 0.070 103.279 0.091
201712 0.055 103.793 0.071
201803 0.062 103.962 0.080
201806 0.054 104.875 0.069
201809 0.027 105.679 0.034
201812 0.043 105.912 0.055
201903 0.061 105.886 0.078
201906 0.068 106.742 0.086
201909 0.071 107.214 0.089
201912 0.083 107.766 0.104
202003 0.078 106.563 0.099
202006 0.059 107.498 0.074
202009 0.073 107.635 0.091
202012 0.081 108.296 0.101
202103 0.069 108.360 0.086
202106 0.080 108.928 0.099
202109 0.084 110.338 0.102
202112 0.094 112.486 0.112
202203 0.098 114.825 0.115
202206 0.110 118.384 0.125
202209 0.123 122.296 0.135
202212 0.146 126.365 0.156
202303 0.165 127.042 0.175
202306 0.186 129.407 0.193
202309 0.204 130.224 0.211
202312 0.227 131.912 0.232
202403 0.246 132.205 0.250
202406 0.286 132.716 0.290
202409 0.311 132.304 0.316
202412 0.334 132.987 0.338
202503 0.378 132.825 0.383
202506 0.389 133.699 0.392
202509 0.396 133.480 0.399
202512 0.427 133.380 0.431
202603 0.454 133.550 0.458
202606 0.489 134.610 0.489

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Bonesupport Holding AB (STU:2B4) Overvalued in 2026?

Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued. The current stock price of €18.64 is trading 53.8% below its estimated GF Value™ of €40.35. GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.

Key valuation signals for STU:2B4:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €40.35 vs. price of €18.64 (53.8% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the STU:2B4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bonesupport Holding AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 70
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
75GF Score

Get the complete analysis for STU:2B4

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.64
Price
€40.35
GF Value